Mechanistic Studies on the Impact of Sleep Deprivation on Gene Regulation
睡眠剥夺对基因调控影响的机制研究
基本信息
- 批准号:10286553
- 负责人:
- 金额:$ 34.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-01 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdultAffectAlzheimer&aposs DiseaseAlzheimer&aposs disease pathologyAlzheimer&aposs disease related dementiaAlzheimer&aposs disease riskAmyloid beta-ProteinBilateralBrain regionCause of DeathCell NucleusCellsCessation of lifeChronicCognition DisordersDevelopmentDisease ProgressionDisease susceptibilityDorsalEconomic BurdenExhibitsFamilyFoundationsFutureGene ExpressionGene Expression RegulationGenesGenetic TranscriptionGenetic TranslationHealthHealthcareHippocampus (Brain)HumanImpaired cognitionIncidenceIndividualInjectionsInvestigationLabelLong-Term EffectsLongevityMedicalMemoryMessenger RNAMolecularMusMutateNeurodegenerative DisordersNeuronsNuclearNuclear RNAOnset of illnessPathogenesisPathologicPathologyPhenotypePolyribosomesPredispositionProcessProteinsPublic HealthRNARNA ProcessingRNA SplicingRNA-Binding ProteinsRegulationResearchResolutionRiboTagRibosomal ProteinsRibosomesRiskScienceSleepSleep DeprivationSleep disturbancesSocietiesSymptomsTauopathiesTechniquesTechnologyTeenagersTherapeuticTranslatingTranslationsUnited StatesViralWild Type Mousecare burdencell typedeprivationdisease phenotypeemerging adultexcitatory neuronexperimental studygenome-widegenome-wide analysisinsightmRNA ExpressionmRNA sequencingmouse modelnovelnovel therapeuticsparent grantpoor sleeprelating to nervous systemresponsesleep patterntau Proteinstau-1transcriptometranscriptome sequencingtranslatomeyoung adult
项目摘要
Project Summary/Abstract
Alzheimer's disease is now considered by some experts to be the third leading cause of death in the United
States, inflicting enormous health care and economic burdens on individuals, families and society. With
advances in medical science and technology substantially extending human lifespan, the numbers of
individuals living longer and affected by Alzheimer's disease and related dementias is expected to increase
significantly. While sleep disturbances have long been viewed as symptoms of Alzheimer's disease and other
neurodegenerative diseases, recent research has suggested that chronic sleep disruption may be a significant
risk factor for Alzheimer's disease decades later. Poor sleep patterns and chronic sleep loss also appear to
accelerate the rate of disease progression and pathogenesis. Acute and chronic sleep deprivation have also
been shown to increase tau pathologies and amyloid beta peptides, pathological hallmarks of Alzheimer's
disease. Recent estimates suggest that over 35% of adults suffer from chronic sleep deprivation making it
imperative that we identify the mechanisms through which chronic sleep deprivation affects Alzheimer's
pathogenesis. The hippocampus, a critical brain region for memory, is particularly susceptible to the effects of
sleep deprivation and is one of the first regions to exhibit phenotypic pathologies in Alzheimer's disease. We
hypothesize that chronic sleep deprivation causes aberrant nuclear RNA splicing and processing, and limits
the available pool of mRNA for translation to affect gene expression in tau pathogenesis. The objective of this
Alzheimer's disease Supplement proposal is to identify the impact of chronic sleep deprivation on
neuronal mRNA processing in the nucleus and to define the translatome of excitatory neurons in the
hippocampus in a mouse model of tauopathy related to Alzheimer's disease and related dementias. We
will use deep neuronal nuclear RNA sequencing to identify the impact of chronic sleep deprivation on mRNA
processing and splicing, and an advanced viral RiboTag strategy to specifically target excitatory neurons in the
hippocampus followed by deep RNA sequencing of the mRNA associated with translating polyribosomes in a
mouse model for tauopathies related to Alzheimer's disease. The results from our multi-level experiments
defining genome-wide impacts of chronic sleep deprivation with cell-type specific resolution on RNA
processing, and the identification of a cell-type specific translatome signature of chronic sleep deprivation, will
provide significant insights into the negative impacts of sleep deprivation on tau pathogenesis related to
Alzheimer's disease, potentially leading to the development of novel therapeutics to counteract the
consequences of sleep loss on cognition and neurodegenerative disorders.
项目摘要/摘要
现在,一些专家认为阿尔茨海默氏病是曼联的第三大死亡原因
国家,给个人,家庭和社会带来巨大的医疗保健和经济负担。和
医学和技术的进步大大延长了人类的寿命,
预计患有长期和受阿尔茨海默氏病影响的人会增加
显著地。长期以来,睡眠障碍一直被视为阿尔茨海默氏病和其他的症状
神经退行性疾病,最近的研究表明,慢性睡眠破坏可能是重要的
几十年后,阿尔茨海默氏病的危险因素。睡眠模式不良和慢性睡眠丧失似乎也
加速疾病进展和发病机理的速度。急性和慢性睡眠剥夺也有
被证明可以增加tau病理和淀粉样β肽,阿尔茨海默氏症的病理标志
疾病。最近的估计表明,超过35%的成年人患有慢性睡眠剥夺使其
我们必须确定慢性睡眠剥夺影响阿尔茨海默氏症的机制
发病。海马是一种记忆的关键大脑区域,特别容易受到影响
睡眠不足,是在阿尔茨海默氏病中表现出表型病理的最早地区之一。我们
假设慢性睡眠剥夺会导致异常的核RNA剪接和处理,并限制
可用的mRNA库翻译以影响tau发病机理中的基因表达。这个目的
阿尔茨海默氏病补充提案是确定慢性睡眠剥夺对
核中的神经元mRNA处理,并定义兴奋性神经元的翻译组
与阿尔茨海默氏病和相关痴呆症相关的小鼠tauopathy小鼠模型中的海马。我们
将使用深层神经元核RNA测序来确定慢性睡眠剥夺对mRNA的影响
加工和剪接,以及一种高级病毒核糖策略,以专门针对兴奋性神经元
海马,然后进行与在A中翻译多核糖体相关的mRNA的深度RNA测序
与阿尔茨海默氏病有关的小鼠模型。我们多级实验的结果
用细胞类型的分辨率定义慢性睡眠剥夺对RNA的慢性睡眠剥夺的影响
处理,以及鉴定细胞类型的特定翻译体剥夺的特异性翻译体特征,将
对睡眠剥夺对与tau发病机理的负面影响提供了重大见解
阿尔茨海默氏病,有可能导致新的疗法发展以抵消
睡眠丧失对认知和神经退行性疾病的后果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EDWIN TED G. ABEL其他文献
EDWIN TED G. ABEL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EDWIN TED G. ABEL', 18)}}的其他基金
University of Iowa Hawkeye Intellectual and Developmental Disabilities Research Center (Hawk-IDDRC)
爱荷华大学鹰眼智力与发育障碍研究中心 (Hawk-IDDRC)
- 批准号:
10451564 - 财政年份:2021
- 资助金额:
$ 34.47万 - 项目类别:
University of Iowa Hawkeye Intellectual and Developmental Disabilities Research Center (Hawk-IDDRC)
爱荷华大学鹰眼智力与发育障碍研究中心 (Hawk-IDDRC)
- 批准号:
10238630 - 财政年份:2021
- 资助金额:
$ 34.47万 - 项目类别:
University of Iowa Hawkeye Intellectual and Developmental Disabilities Research Center (Hawk-IDDRC)
爱荷华大学鹰眼智力与发育障碍研究中心 (Hawk-IDDRC)
- 批准号:
10669135 - 财政年份:2021
- 资助金额:
$ 34.47万 - 项目类别:
Mechanistic Studies on the Impact of Sleep Deprivation on Gene Regulation
睡眠剥夺对基因调控影响的机制研究
- 批准号:
10612844 - 财政年份:2019
- 资助金额:
$ 34.47万 - 项目类别:
Mechanistic Studies on the Impact of Sleep Deprivation on Gene Regulation
睡眠剥夺对基因调控影响的机制研究
- 批准号:
9980258 - 财政年份:2019
- 资助金额:
$ 34.47万 - 项目类别:
Mechanistic Studies on the Impact of Sleep Deprivation on Gene Regulation
睡眠剥夺对基因调控影响的机制研究
- 批准号:
10398122 - 财政年份:2019
- 资助金额:
$ 34.47万 - 项目类别:
Molecular, Cellular and Circuit Effects of Sleep Deprivation on Hippocampal Function
睡眠剥夺对海马功能的分子、细胞和回路影响
- 批准号:
10431989 - 财政年份:2018
- 资助金额:
$ 34.47万 - 项目类别:
相似国自然基金
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
儿童期受虐经历影响成年人群幸福感:行为、神经机制与干预研究
- 批准号:32371121
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
依恋相关情景模拟对成人依恋安全感的影响及机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
依恋相关情景模拟对成人依恋安全感的影响及机制
- 批准号:32200888
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
生活方式及遗传背景对成人不同生命阶段寿命及死亡的影响及机制的队列研究
- 批准号:82173590
- 批准年份:2021
- 资助金额:56.00 万元
- 项目类别:面上项目
相似海外基金
Climate Change Effects on Pregnancy via a Traditional Food
气候变化通过传统食物对怀孕的影响
- 批准号:
10822202 - 财政年份:2024
- 资助金额:
$ 34.47万 - 项目类别:
Targeting Menin in Acute Leukemia with Upregulated HOX Genes
通过上调 HOX 基因靶向急性白血病中的 Menin
- 批准号:
10655162 - 财政年份:2023
- 资助金额:
$ 34.47万 - 项目类别:
Targeting Alcohol-Opioid Co-Use Among Young Adults Using a Novel MHealth Intervention
使用新型 MHealth 干预措施针对年轻人中酒精与阿片类药物的同时使用
- 批准号:
10456380 - 财政年份:2023
- 资助金额:
$ 34.47万 - 项目类别:
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
- 批准号:
10660332 - 财政年份:2023
- 资助金额:
$ 34.47万 - 项目类别:
Protein tyrosine phosphatase non-receptor 14 in vascular stability and remodeling
蛋白酪氨酸磷酸酶非受体 14 在血管稳定性和重塑中的作用
- 批准号:
10660507 - 财政年份:2023
- 资助金额:
$ 34.47万 - 项目类别: